Nanobac Pharmaceuticals, Incorporated NNBP Stock
Nanobac Pharmaceuticals, Incorporated Price Chart
Nanobac Pharmaceuticals, Incorporated NNBP Financial and Trading Overview
| Nanobac Pharmaceuticals, Incorporated stock price | 0.0001 USD |
| Previous Close | 1.0E-6 USD |
| Open | 1.0E-6 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 1.0E-6 - 1.0E-6 USD |
| 52 Week Range | 1.0E-6 - 0.0001 USD |
| Volume | 1K USD |
| Avg. Volume | 0 USD |
| Market Cap | 1.25K USD |
| Beta (5Y Monthly) | -31.168308 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (2.18%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NNBP Valuation Measures
| Enterprise Value | 4.12M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.070767835 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 233.714 |
| Enterprise Value/EBITDA | -1.036 |
Trading Information
Nanobac Pharmaceuticals, Incorporated Stock Price History
| Beta (5Y Monthly) | -31.168308 |
| 52-Week Change | 900.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 1.0E-6 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0001 USD |
NNBP Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 0 |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2007 |
| Most Recent Quarter (mrq) | December 31, 2007 |
| Next Fiscal Year End | December 31, 2008 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -25162.085% |
| Gross Margin | 17.60% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -36.83% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 17.62K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | 86.59% |
| Gross Profit (ttm) | 3.1K USD |
| EBITDA | -3973509 USD |
| Net Income Avi to Common (ttm) | -6576111 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.93K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 4.12M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.005 |
| Book Value Per Share (mrq) | -0.009 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -910886 USD |
| Levered Free Cash Flow (ttm) | 1.03M USD |
Profile of Nanobac Pharmaceuticals, Incorporated
| Country | United States |
| State | FL |
| City | Tampa |
| Address | 3000 Bayport Drive |
| ZIP | 33607 |
| Phone | 813-865-1125 |
| Website | N/A |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1 |
Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It manufactures and markets in vitro diagnostic (IVD) kits, such as assays, antibodies, and reagents for detecting CNPs. The company's diagnostic assays comprise NANO-CAPTURE and NANO-SERO. Additionally, it conducts research and clinical studies in the development of urological diseases, including chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and polycystic kidney diseases, as well as cardiovascular diseases. Nanobac Pharmaceuticals, Incorporated was formerly known as HealthCentrics Inc. and changed its name to Nanobac Pharmaceuticals, Incorporated in December 2002. The company was founded in 1994 and is based in Tampa, Florida.
Q&A For Nanobac Pharmaceuticals, Incorporated Stock
What is a current NNBP stock price?
Nanobac Pharmaceuticals, Incorporated NNBP stock price today per share is 0.0001 USD.
How to purchase Nanobac Pharmaceuticals, Incorporated stock?
You can buy NNBP shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nanobac Pharmaceuticals, Incorporated?
The stock symbol or ticker of Nanobac Pharmaceuticals, Incorporated is NNBP.
Which industry does the Nanobac Pharmaceuticals, Incorporated company belong to?
The Nanobac Pharmaceuticals, Incorporated industry is Biotechnology.
How many shares does Nanobac Pharmaceuticals, Incorporated have in circulation?
The max supply of Nanobac Pharmaceuticals, Incorporated shares is 1.25B.
What is Nanobac Pharmaceuticals, Incorporated Price to Earnings Ratio (PE Ratio)?
Nanobac Pharmaceuticals, Incorporated PE Ratio is now.
What was Nanobac Pharmaceuticals, Incorporated earnings per share over the trailing 12 months (TTM)?
Nanobac Pharmaceuticals, Incorporated EPS is 0 USD over the trailing 12 months.
Which sector does the Nanobac Pharmaceuticals, Incorporated company belong to?
The Nanobac Pharmaceuticals, Incorporated sector is Healthcare.